Company intelligence / Profile preview

Salve Therapeutics

Los Angeles*, California, United Statessalvetherapeutics.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

Salve Therapeutics is in the early stages of development. The company has not yet reported clinical results but is focused on building a computational platform to design novel viral vectors for gene therapy applications.[1][3] No clinical trial data or human results are available as of now.

Therapeutic areas: Rare Diseases
Modalities: Viral gene therapiesViral biologics[1][3][4]
Industry: Biotech

Partnerships

Seeking partnerships with large biopharma companies to co-develop cell and gene therapies; no formal partnerships announced yet.[4]

Beyond the preview

Go deeper on Salve Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salve Therapeutics.

Explore the full profile